VBK - ETF AI Analysis
Top Page
Vanguard Small-Cap Growth ETF (VBK)
Rating:65Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year and over the past month, indicating solid recent momentum in its holdings.
Low Expense Ratio
With a very low ongoing fee, more of the fund’s returns stay in investors’ pockets instead of going to costs.
Broad Sector Diversification
Holdings spread across technology, industrials, health care, consumer, financials, and other sectors help reduce the impact of weakness in any single industry.
Negative Factors
Heavy U.S. Concentration
Almost all of the fund’s assets are invested in U.S. companies, offering very limited international diversification.
Exposure to Volatile Growth Segments
Its focus on small-cap growth stocks in areas like technology and health care can lead to larger price swings during market downturns.
Some Lagging Top Holding
At least one of the largest positions has delivered weak performance this year, which can slightly drag on overall returns.
VBK vs. SPDR S&P 500 ETF (SPY)
AUM24.19B
RegionNorth America
Expense Ratio0.05%
Beta1.13
IssuerVanguard
Inception DateJan 26, 2004
Dividend Yield0.44%
Asset ClassEquity
Index TrackedCRSP US Small Growth
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume191,374
30 Day Avg. Volume241,864
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
438.64Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering546
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VBK Summary
Vanguard Small-Cap Growth ETF (VBK) tracks the CRSP US Small Cap Growth Index, focusing on smaller U.S. companies that are growing quickly. It owns hundreds of stocks across many sectors like technology, industrials, and health care, including names such as Ciena and Casey’s General Stores. Investors might consider VBK if they want long-term growth potential and diversification beyond large, well-known companies. However, because it focuses on smaller growth stocks, the share price can be more volatile and may go up and down more sharply than the overall market.
How much will it cost me?The Vanguard Small-Cap Growth ETF (VBK) has an expense ratio of 0.07%, which means you’ll pay $0.70 per year for every $1,000 invested. This is lower than average because it’s passively managed, aiming to track the CRSP US Small Cap Growth Index rather than actively picking stocks.
What would affect this ETF?VBK's focus on U.S. small-cap growth stocks, particularly in sectors like technology and healthcare, positions it to benefit from innovation and economic expansion. However, its exposure to smaller companies makes it more vulnerable to market volatility, interest rate hikes, and economic slowdowns, which could negatively impact growth-oriented investments.
VBK Top 10 Holdings
VBK’s story is all about fast-moving U.S. small-cap growth names, with a clear tilt toward tech and innovation. Astera Labs and Credo Technology are rising standouts, helping drive the fund as demand for data and connectivity heats up. Bloom Energy is also adding spark with steady gains, even if its balance sheet keeps some investors cautious. On the flip side, Ciena and Rocket Lab have been lagging lately, acting like a bit of drag on performance. Overall, the ETF is diversified across sectors but leans heavily on smaller U.S. tech and industrial disruptors.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Astera Labs, Inc. | 1.37% | $642.50M | $62.06B | 291.71% | 68 Neutral | |
| Ciena | 1.14% | $531.59M | $63.05B | 441.01% | 70 Outperform | |
| Rocket Lab USA | 1.13% | $527.28M | $45.90B | 76.70% | 57 Neutral | |
| Credo Technology Group Holding Ltd | 1.06% | $497.01M | $44.17B | 130.22% | 77 Outperform | |
| Bloom Energy | 1.05% | $491.94M | $66.41B | 861.68% | 62 Neutral | |
| Coherent Corp | 0.94% | $438.92M | $60.14B | 223.48% | 66 Neutral | |
| Comfort Systems | 0.89% | $416.48M | $60.97B | 229.32% | 80 Outperform | |
| Revolution Medicines | 0.86% | $404.46M | $39.11B | 389.21% | 52 Neutral | |
| Lumentum Holdings | 0.85% | $395.32M | $59.76B | 730.24% | 61 Neutral | |
| Natera | 0.82% | $383.29M | $39.08B | 81.96% | 73 Outperform |
VBK Technical Analysis
Neutral
―
Price Trends
349.60
Positive
332.73
Positive
319.29
Positive
Market Momentum
1.24
Positive
47.75
Neutral
22.95
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VBK, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 355.92, equal to the 50-day MA of 349.60, and equal to the 200-day MA of 319.29, indicating a neutral trend. The MACD of 1.24 indicates Positive momentum. The RSI at 47.75 is Neutral, neither overbought nor oversold. The STOCH value of 22.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for VBK.
VBK Peer Comparison
Comparison Results
Performance Comparison
VBK
Vanguard Small-Cap Growth ETF
350.89
72.31
25.96%
IJR
iShares Core S&P Small Cap ETF
―
―
―
IWM
iShares Russell 2000 ETF
―
―
―
VB
Vanguard Small-Cap ETF
―
―
―
VBR
Vanguard Small Cap Value ETF
―
―
―
IWO
iShares Russell 2000 Growth ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents